Lions WR Josh Reynolds and TE Brock Wright were activated from the COVID list on Monday. Both guys should be available for this weekend's finale vs. the Packers. WR Kalif Raymond remains on the COVID list for now.
The Lions signed WR Josh Reynolds to a 2-year deal with a "max value of $12 million," according to NFL Network's Mike Garafolo. Reynolds joined Detroit last November after getting dumped by the Titans. He played 63+% of the offensive snaps in all 7 of his games with the Lions but averaged just 5.1 targets, 2.7 catches and 43.7 yards per game. We'll see what else Detroit does to address the WR room this offseason, but Reynolds isn't a great bet to be a real fantasy asset in 2022.
The Lions on Monday placed WR Josh Reynolds on the COVID list. Unless we learn that he's a close contact, this should knock Reynolds out of any Week 17 fantasy-lineup consideration -- even if he makes it back in time for the game.
Lions WRs Josh Reynolds (thigh) and Kalif Raymond (shoulder) are active for today's game vs. the Falcons. Neither is a recommended fantasy play with Tim Boyle under center.
Lions WRs Josh Reynolds (thigh) and Kalif Raymond (shoulder) are questionable for Sunday's game vs. the Falcons. Both guys got in 3 limited practices this week and figure to play on Sunday. But they carry more risk than usual -- to go along with their unexciting ceilings.
The Lions claimed WR Josh Reynolds off waivers from the Titans. Reynolds could find playing time in Detroit's weak WR corps but is unlikely to become a fantasy factor. You can leave him on the waiver wire.
Based on our award-winning projections, an axis of data points give insights far deeper than a ranking
Round-by-Round Draft Strategy Guides, Sleepers, Undervalued Players, Busts and Handcuffs
Command your entire draft with a dynamic tool synced to your league. Updating and adapting in real time.
Quickly find the free-agent gems, pull the trigger on the perfect trade & make the right start/sit decisions.
$6/month thereafter, billed semi-annually, one-click cancel anytime.
Follow us on